Key statistics
As of last trade, Alkermes Plc (8AK:FRA) traded at 25.20, 14.55% above the 52 week low of 22.00 set on Sep 16, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 25.20 |
|---|---|
| High | 25.20 |
| Low | 25.20 |
| Bid | 25.20 |
| Offer | 25.80 |
| Previous close | 24.80 |
| Average volume | 199.56 |
|---|---|
| Shares outstanding | 166.65m |
| Free float | 163.58m |
| P/E (TTM) | 21.12 |
| Market cap | 5.04bn USD |
| EPS (TTM) | 1.43 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 08:21 GMT.
More ▼
Press releases
- Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026
- Alkermes plc Announces CEO Succession Plan
- Alkermes to Present at the TD Cowen 46th Annual Health Care Conference
- Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
- Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
- Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
- Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
More ▼
